Home » Authors » Nuala Moran

Articles by Nuala Moran

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Feb. 14, 2001

British Biotech's Marimistat Fails In Promising Indication

Feb. 14, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Feb. 14, 2001

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Feb. 14, 2001

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

Feb. 14, 2001

British Biotech's Marimistat Fails In Promising Indication

Feb. 14, 2001

Protherics Gains U.S. Approval Of CroFab, Raises £3.1M Privately

Feb. 7, 2001

SR Pharma, YM Biosciences Combine Products For Trial

Feb. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 1, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 1, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment
BioWorld MedTech
Nanocube Health Ltd. is developing accessible, low-cost nanorobots that could revolutionize diagnosis and treatment of hard-to-diagnose cancers, with pancreatic...
Cureverse, Angelini ink $360M deal for oral Alzheimer’s drug
BioWorld
Cureverse Inc. and Angelini Pharma SpA signed a potential $360 million deal for CV-01, an oral small-molecule candidate for Alzheimer’s disease and neurological...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.